EFG Asset Management (Americas)’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,274	Closed	-$252K	–	139
2023 Q4	$252K	Buy	+5,274	New	+$252K	0.05%	133
2021 Q4	–	Sell	-2,979	Closed	-$269K	–	138
2021 Q3	$269K	Buy	+2,979	New	+$269K	0.05%	133